UK drugs regulator plays down Brexit disruption threat

Britain's drugs regulator said on Tuesday it would work to minimise disruption caused by the country leaving the European Union as it tried to allay some of the worst fears of pharmaceutical companies.The highly regulated drugs industry is concerned about Brexit fallout as the European Medicines Agency (EMA) relocates from London to Amsterdam, creating uncertainty about drug approvals after 2019.The Medicines and Healthcare products Regulatory Agency (MHRA) said in an update on its website that